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Deconvolving mutational patterns of poliovirus
outbreaks reveals its intrinsic fitness landscape
Ahmed A. Quadeer 1, John P. Barton2, Arup K. Chakraborty3,4,5,6,7* & Matthew R. McKay 1,8*
Vaccination has essentially eradicated poliovirus. Yet, its mutation rate is higher than that of
viruses like HIV, for which no effective vaccine exists. To investigate this, we infer a fitness
model for the poliovirus viral protein 1 (vp1), which successfully predicts in vitro fitness
measurements. This is achieved by first developing a probabilistic model for the prevalence of
vp1 sequences that enables us to isolate and remove data that are subject to strong vaccine-
derived biases. The intrinsic fitness constraints derived for vp1, a capsid protein subject to
antibody responses, are compared with those of analogous HIV proteins. We find that vp1
evolution is subject to tighter constraints, limiting its ability to evade vaccine-induced
immune responses. Our analysis also indicates that circulating poliovirus strains in unim-
munized populations serve as a reservoir that can seed outbreaks in spatio-temporally
localized sub-optimally immunized populations.
https://doi.org/10.1038/s41467-019-14174-2 OPEN
1 Department of Electronic and Computer Engineering, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
2 Department of Physics and Astronomy, University of California, Riverside, CA 92521, USA. 3 Department of Chemical Engineering, Massachusetts Institute
of Technology, Cambridge, MA 02139, USA. 4Department of Physics, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. 5Department of
Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. 6 Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA.
7 Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. 8Department of Chemical and
Biological Engineering, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China. *email: arupc@mit.edu; m.mckay@ust.hk
NATURE COMMUNICATIONS |          (2020) 11:377 | https://doi.org/10.1038/s41467-019-14174-2 | www.nature.com/naturecommunications 1
12
34
56
78
9
0
()
:,;
The human immune system is incredibly effective at com-bating diverse pathogens. Some viruses with high mutationrates, however, have demonstrated an ability to evade
immune responses through mutation while still remaining suffi-
ciently fit to propagate infection. Prominent examples of viruses
with high mutation rates include poliovirus (PV), human
immunodeficiency virus (HIV), measles virus (MeV), and hepa-
titis C virus (HCV). PV1 and MeV2 are effectively controlled by
vaccination, despite their high mutation rate. However, efforts
continue in the quest for effective vaccines against HIV3 and
HCV4. A goal is to identify the features of these viruses that
explain their susceptibility or resistance to control by vaccination.
For the latter class (e.g., HIV, HCV), one also aims to develop an
understanding of the specific sets of viral protein residues that are
vulnerable to mutations, and can hence serve as targets for
vaccine-induced immune responses.
Here, we focus on PV and contrast it with HIV. PV replicates
in the gastrointestinal (GI) tract during the initial phase of
infection. In rare cases (around 1%), PV reaches the central
nervous system and may lead to poliomyelitis—a disease
associated with paralysis1. There are two PV vaccines: the
inactivated PV vaccine5 (IPV), and the oral PV vaccine6 (OPV).
IPV induces a humoral immune response only and is known to
induce weak GI immunity against wild-type PV. OPV, in
contrast, elicits both cellular and humoral immune responses as
it is based on a live attenuated virus which replicates in the GI
tract, providing better GI immunity against wild-type PV. Both
vaccines have been successful in the global fight against PV.
Thanks to the Global Polio Eradication Initiative (GPEI) of the
World Health Organization (WHO), PV has now been largely
eradicated, with the exception of a few countries where it is still
endemic7.
An interesting aspect of PV is that its mutation rate is higher
than that of HIV (~10−4 vs. ~10−5 substitutions per nucleotide
per replication cycle8). This, in turn, raises the question: Why
have vaccines against PV proven substantially more effective than
those against HIV? HIV is well known for its ability to evade
immune control, and for sustaining a large number of mutations
while still remaining strongly pathogenic9. It may be that PV is
more successfully controlled by vaccination in part because PV is
under more stringent evolutionary constraints compared to HIV,
limiting its ability to escape immunity through mutation to
strains that are simultaneously sufficiently fit and not subject to
immune attack. However, a systematic characterization of such
constraints has yet to be established.
We aim to address this question by inferring the fitness
landscape of PV, and subsequently comparing it with that of HIV.
In previous work10–15, we developed maximum entropy-based
computational methods for inferring the fitness landscape of HIV
proteins from sequence data. This involves first inferring a pre-
valence landscape which describes the probability of observing a
sequence in circulation. For HIV, this prevalence landscape seems
to serve as a rough proxy for its fitness. Several key factors have
been identified to underlie this relatively simple relationship for
HIV proteins10–17. For many HIV proteins, the inferred fitness
landscapes were validated by demonstrating a high correlation of
the inferred landscape-based predictions with in vitro fitness
measurements and in vivo studies of virus evolution in
patients10–15. However, applying the same methods to PV pre-
sents a challenge. All available PV sequences are sampled from
the post-vaccination era—during which, as a consequence of the
GPEI, it has been largely limited to the endemic regions or to
outbreaks which have occurred sporadically—and it is not clear a
priori whether one can disentangle intrinsic fitness effects from
the biased vaccine-driven evolution in the inferred prevalence
landscape in a simple way18.
Here, we first present an analysis of the prevalence landscape of
a PV protein. We focus on the capsid vp1 protein because it is the
major target of neutralizing antibodies19 and it has the highest
number of available sequences (see the “Methods” section). We
observe an emergent structure in the inferred prevalence land-
scape, which seems to disentangle the effects of intrinsic fitness
and vaccine-derived selective pressures. We find that the land-
scape decouples into two main regions: (i) a region associated
with spatio-temporally localized outbreaks, representative of PV
evolution under vaccine-mediated immune pressure; and (ii) a
region largely representing natural PV evolution in unimmunized
populations, which is thus expected to be concordant with evo-
lution under intrinsic constraints.
This structure is revealed through a decomposition of the
inferred landscape into prevalence peaks20,21. Most such peaks
are associated with mutations in the antigenic sites (targets of
antibodies), suggesting that they represent subpopulations of
viruses exhibiting immune escape. Inspection of the temporal and
geographical distribution of vp1 sequences that lie on these peaks
reveals that they represent spatio-temporally localized polio
outbreaks. Distinct from these, a single peak which is populated
by the largest number of sequences is shown to be representative
of natural evolution of vp1 in largely unimmunized populations.
Fitness predictions using a landscape inferred exclusively from
the sequences from this peak yield an excellent correspondence
with experimental fitness measurements, supporting the conclu-
sion that it is a good proxy for the vp1 intrinsic fitness landscape.
We also find that this particular peak serves as a reservoir that can
transmit PV to cause outbreaks in sub-optimally immunized
populations.
Comparing the obtained vp1 landscape with that for two HIV
proteins—p24 (capsid) and gp160 (envelope)—suggests that
PV vp1 is more constrained in its evolution than corresponding
HIV proteins. Thus, despite the fact that PV has a higher
mutation rate than HIV, the fitness costs of mutations appear to
be more likely to be higher. This provides a partial rationale for
why vaccines against PV have been so successful compared with
HIV, for which immense efforts for an effective vaccine are still
ongoing. Some other reasons include the fact that HIV infects
immune cells22 and has a low spike density that may limit anti-
body binding23.
Results
Inferred vp1 landscape reflects statistics of observed data. As a
first step in inferring the fitness landscape of vp1, as established
previously for HIV proteins10–15, we sought to infer a probabil-
istic model, referred to as a prevalence landscape, that approxi-
mately describes the distribution of the sequences observed in the
multiple sequence alignment (MSA). In this model, the prob-
ability of observing an arbitrary sequence b ¼ b1; b2; ¼ ; bNf g
is given by
P bð Þ ¼ e
E bð Þ
Q
; ð1Þ
where
E bð Þ ¼ 
XN
i¼1
hi bið Þ 
XN1
i¼1
XN
j¼iþ1
Jij bi; bj
 
:
following the language of statistical physics, E is referred to as
the energy of the sequence. Here, N is the length of the sequence,
bi represents the amino acid present at the ith residue, and
Q ¼Pb eE bð Þ is a normalization factor. The energy of a
sequence is inversely related to its prevalence, and therefore a
sequence with lower energy is predicted to be more prevalent
(and vice versa). The energy depends on the model parameters
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hi(x) (called fields that represent the effects of mutations at
individual residues) and Jij(x, y) (called couplings that represent
the interaction between mutations at different residues), which
are specified such that they reproduce the single and double
mutant probabilities observed in the MSA (see the “Methods”
section). Monte Carlo-based approaches are often used to infer
these parameters, but such methods generally become compu-
tationally prohibitive for large systems24,25. Here, we inferred
the model parameters using a recently proposed efficient
approach known as adaptive cluster expansion (ACE)24,26. The
single and double mutant probabilities of the inferred model
matched well with those of the MSA, demonstrating successful
model fit (Fig. 1a, b). Moreover, although not used as constraints
for training the model, additional statistics computed from the
inferred model—including the triple mutant probabilities, the
distribution of the number of mutants, and the distribution of
the number of first and second most-prevalent mutant amino
acids per sequence—matched well with those of the MSA
(Fig. 1c–f). These results demonstrate the accuracy by which the
inferred model reflects statistical variations in the observed
sequence data for vp1. We obtained prevalence landscapes with
similar accuracy for the HIV proteins p24 and gp160 (Supple-
mentary Figs. 1 and 2), as reported previously10,11,13,14.
Most local peaks in vp1 landscape reflect polio outbreaks. For
numerous HIV and HCV proteins, the prevalence landscapes
have been shown to be predictive of intrinsic fitness10–15,27,28.
Interestingly, such a simple correspondence between prevalence
and intrinsic fitness landscape is not observed for influenza A
virus (IAV), due to the evolution of IAV being driven strongly
out of steady state by effective herd memory responses29,30.
Like IAV, PV evolution is known to be under sustained and
effective vaccine-mediated immune pressure, which is expected
to induce a similar significant bias in the MSA. That is, the vp1
prevalence landscape is expected to reflect a potentially com-
plex combination of both the intrinsic and vaccine-mediated
evolution of PV, and the extent to which these factors may be
easily uncoupled is unclear. Here, we show that in the case of
PV, intrinsic fitness constraints and vaccine-induced effects can
be apparently disentangled by analyzing the structure of the
inferred vp1 prevalence landscape using meta data. This is done
by obtaining a low-dimensional representation of the landscape
in terms of its local peaks, and performing an antigenic, geo-
graphical, and temporal analysis of the local peaks to explore
their evolutionary origin. Previously, a similar analysis showed
such peaks in HIV to be associated with immune escape20. In
case of PV, this analysis allows us to suppress the bias caused by
the vaccine-induced immune pressure and infer a meaningful
fitness landscape model, as we discuss in the subsequent
section.
We obtained a low-dimensional representation of the vp1
landscape by following a steepest ascent walk from each sequence
in the MSA (see the “Methods” section). This procedure
produced 25 local peaks in the vp1 landscape. We ranked these
according to the number of MSA sequences that correspond to
each peak, with the most-populous peak ranked number 1. This
analysis revealed that the great majority of sequences (86%) lie on
the top 10 peaks (Fig. 2a). An important feature of our landscape
is that it is inferred by including statistical correlations between
mutations at different residues. A model obtained without the
effect of coupled mutations (Supplementary Note 1) results in a
landscape with a single peak. We also confirmed, following a
procedure similar to ref. 20, that the observed multiple local peaks
in the vp1 landscape are not an artifact of finite sampling
(Supplementary Note 2). Moreover, the observed peaks are found
to be fairly robust to the regularization strength, or to sequence
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Fig. 1 The inferred Potts model accurately captures the single and double mutant probabilities, as well as the higher order statistics of the observed
sequences. a, b Comparison of the data statistics used to train the model: a the single mutant probability, and b the double mutant probability of the
observed sequences and of those obtained from the inferred Potts model. c–f Comparison of the data statistics predicted by the inferred Potts model: c the
triple mutant probability, d the distribution of the number of mutations, e the distribution of the first most-prevalent mutant amino acid, and f the
distribution of the second most-prevalent mutant amino acid in the observed sequences and the inferred Potts model. For model prediction related to
connected correlations in the data, i.e., the correlations which cannot be explained by lower order mutant probabilities, see Supplementary Fig. 9.
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reweighting used in the landscape inference procedure designed
to compensate spatio-temporal biases in the PV sequence data
(Supplementary Notes 3 and 4).
We investigated the local peaks by scanning the most fit
sequence corresponding to each peak, referred to as a peak
sequence (see the “Methods” section), for the presence of
mutations at antigenic sites (groups of residues known to be
targeted by neutralizing antibodies). Two out of three antigenic
sites of PV are located on the vp1 protein31. Specifically, antigenic
site 1 (Ags1) comprises three distinct segments of vp1: residues
91–102, residue 254, and residue 168; while antigenic site 2
(Ags2) consists of a segment from vp1 corresponding to residues
221–226, along with two segments of vp2. Here we defined
mutation as any amino acid difference from the consensus
sequence of the MSA (i.e., a sequence comprising the most
frequently observed amino acid observed at each position in the
MSA). Compared with the consensus sequence, we found that
72% of the peak sequences (18 out of 25) had mutations in at least
one antigenic site of vp1 (Fig. 2b), suggesting the likely presence
of escape mutations from natural or vaccine-induced antibodies.
Of the 25 peak sequences, closer analysis revealed 16 unique sets
of amino acids at antigenic sites (Fig. 2b), depicting the multiple
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possible pathways employed by the virus to avoid immune
pressure. Further analysis showed that for 10 of these peak
sequences the antigenic-site associations were statistically sig-
nificant (Fig. 2c; see the “Methods” section). We also found a few
mutations in the peak sequences, at residues 169, 252, and 257,
that have close physical proximity (i.e., at a distance of <8 Å) to
the residues in Ags1. Mapping the known antigenic sites and
these neighboring residues onto the 3D crystal structure of the PV
capsid indicates that the latter are reasonably exposed on the viral
surface as well (Fig. 2d). This suggests that these residues might
be novel antigenic residues which contribute to escape from
antibodies.
To further explore the evolutionary origin of the peaks, we
conducted a geographical and temporal analysis of the
vp1 sequences in each peak. Specifically, we used the country
and year information, extracted from the compiled metadata of
observed vp1 sequences (Supplementary Data 1), to compute the
geographical and temporal distribution of the sequences in each
peak. This revealed a strong association with PV outbreaks in a
particular region (Fig. 3a) and time (Fig. 3b) for all but the most-
populous peak 1, in which sequences from different regions at
different times were present. Investigation of the literature reports
associated with the sequences associated with each peak further
indicates that the outbreaks associated with the majority of peaks
(peak 1 being an exception) occurred due to decrease in selective
pressure in largely immunized populations. We can broadly
divide these peaks into three categories according to the cause
reported for the representative outbreaks (Fig. 3c), as discussed
below.
First, peaks 2–4, 6, 8, and 9 represented outbreaks in polio-
free regions due to large gaps in immunization or incomplete
immunization dosage (Fig. 3c; Supplementary Note 5). Both of
these are known to cause a decrease of antibody titers in the
immunized population, facilitating the occurrence of an out-
break32,33. Second, peak 5 consisted of a majority of sequences
from the 2013 outbreak in Israel, which was seemingly caused
by the exclusive use of IPV. Due to the vaccine-associated
disease concern of OPV, some WHO-declared polio-free
regions have switched to IPV, which is known to induce
inferior (but non-zero34) GI immunity compared with OPV. In
Israel, which adopted IPV-only dosage, circulation of wild-type
PV was reported in a well-immunized (IPV-only) population
(>95%) due to importation of wild-type PV from a neighboring
country35. Third, peak 10 was associated with an outbreak
caused by a wild-vaccine recombinant virus reported to
circulate in China36 during 1991–1993. Such a recombinant
strain may emerge in regions where both wild-type and
vaccine-derived viruses are prevalent and circulate in the
immunized population due to potentially reduced immunity
against it.
Note that unlike the above-mentioned peaks, peak 7 was
associated with the circulation of PV in geographically localized
endemic regions of Pakistan and Afghanistan37 during
2010–2011, where a good proportion of population was
unimmunized (immunization coverage was only 68–74% during
this period38,39). Thus, it is not clear if this peak is associated with
an immunized population. Nonetheless, the number of sequences
in this peak was quite small, and our results were unaffected
regardless of whether we associate this peak to immunized or
unimmunized population (Supplementary Note 6).
In contrast to the peaks discussed above, sequences in the
most-populous peak 1 were well-distributed both temporally and
geographically (Fig. 3a, b). This, along with the observation of no
antigenic mutations in the corresponding peak sequence (Fig. 2),
suggests that peak 1 may be representative of natural PV
evolution in a mainly unimmunized population. To investigate
this further we conducted a detailed analysis of the sequences in
peak 1.
Peak 1 captures evolution in largely unimmunized population.
Examination of reports in the literature associated with the
sequences in peak 1 (Supplementary Table 1) revealed that it was
strikingly associated with circulation of PV in largely unim-
munized populations. All of the ~74% of sequences in this peak
for which source information was available were obtained from
either unimmunized individuals or from endemic countries,
where wild PV is/was circulating in unimmunized populations.
Specifically, peak 1 included sequences related to the occurrence
of poliomyelitis among clinically established unimmunized chil-
dren in Bulgaria40. It also included sequences from the endemic
countries of Pakistan and Afghanistan in which wild-type PV
transmission has never been interrupted1 and sequences from the
2010 Tajikistan outbreak in which the majority of infected indi-
viduals were reported to have no detectable antibodies for PV2
and PV3 and hence were considered likely to be unvaccinated41.
While a systematic serological study similar to refs. 41,42 was not
performed for the Namibia 2006 outbreak43 sequences present in
peak 1, the majority of infected individuals were reported to be
adults (born before 1990), which were most likely unvaccinated
during the initial 1990–1995 OPV immunization activities in
Namibia (as these specifically targeted children under 5 years
of age).
Our analysis of the landscape inferred from the available
vp1 sequences further suggests that the sequences in peak 1 act as
a reservoir that transmits PV to different regions and causes
outbreaks. This was established by quantifying the potential
pathways for PV strains to move from one peak in the landscape
to another using a zero-temperature Monte Carlo computational
procedure (see the “Methods” section). This study indicated that
peak 1 was distinct from other peaks as it was the most highly
networked peak, with inward and outward pathways to almost all
the other peaks in the landscape (Fig. 4). Interestingly, WHO has
noted this potential chain of wild PV transmission from current
endemic countries to the polio-free regions, and in order to stop
this transmission route it has recently recommended endemic
countries to ensure that all people traveling outside the country
are vaccinated44. This result further supports the notion that peak
1 represents the evolution of PV in unimmunized population and
it seems to act as a source of PV outbreaks in different parts of the
world.
These results, which provide evidence that peak 1 is representa-
tive of PV in largely unimmunized populations, suggest that this
part of the landscape may reflect natural PV evolution. This
conclusion raises the question: Can the sequences in peak 1 provide
information on the intrinsic evolutionary constraints on PV?
Model predictions correlate well with fitness experiments. A
key goal of this study is to investigate the intrinsic fitness land-
scape of vp1. Based on the observations described above, we re-
inferred a maximum entropy model based only on the sequences
corresponding to peak 1 in order to minimize bias due to vaccine-
driven evolution. We then compared fitness predictions based on
this model with experimental replicative fitness measurements
available from the literature45–49.
We used the energy of a sequence computed using the inferred
model (Eq. (1)), which is inversely related to prevalence/fitness, as a
proxy for fitness. To test our model, we investigated whether the
sequence energy values correlated negatively with corresponding
experimental fitness measurements. The experimental fitness values
for PV were obtained from studies45,48–50 in which Mahoney strain
variants were constructed using site-directed mutagenesis and the
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each of the 10 most populated peaks. Each subfigure plots the percentage of sequences in a particular peak with respect to the sampling year. The peaks
are colored according to the scheme specified in a. c Association of local peaks in the landscape with largely unimmunized or immunized population based
on the literature associated with the available sequence data. The outline of boxes (representing peaks) is colored according to the scheme specified in a.
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replicative capacity of each variant was measured (see Supplemen-
tary Table 2 for the list of experimental fitness measurements and
Supplementary Note 7 for the criteria used to select these
measurements from each study). Comparing these fitness measure-
ments with model energies revealed a strong negative correlation
(Spearman correlation ρs=−0.83, p= 4.5 × 10−8; two-tailed test)
(Fig. 5a). These results corroborate that our inferred model, based
on peak 1 sequences only, serves as a meaningful proxy for the
intrinsic vp1 fitness landscape. We note that a model inferred based
on all sequences or all sequences except those in peak 1 led to a
comparatively much lower correlation (ρs=−0.54, p= 2 × 10−3
and ρs=−0.51, p= 3 × 10−3, respectively) (Supplementary Fig. 4),
indicating that the remaining peaks in the landscape have a
strong effect of vaccine-induced immune pressure and thus, do not
clearly reflect the intrinsic fitness constraints on natural PV
evolution.
The strong couplings between pairs of interacting sites inferred
from maximum entropy models are known to be informative
about structural and functional properties of viral proteins13,51,52
as well as other proteins53,54. Investigating the strongest couplings
in the inferred vp1 model, corresponding to the 1% of those with
the highest magnitudes, showed that 48% of these involve N-
terminus vp1 residues, which form an interface with the capsid
vp4 protein known to be critical for viral stability55 (Fig. 5b). This
suggests that many of the strongest couplings encode information
about constraints on the vp1–vp4 protein structure. That is,
coupled mutations affect viral fitness together due to structural
reasons. This result sheds light on one aspect of the biological
interpretation of the intrinsic fitness landscape that we have
inferred after carefully removing sampling biases due to localized
outbreaks, vaccination, etc.
Comparison with other standard methods. The analysis above
demonstrates the ability of the maximum entropy model (pre-
valence landscape) to distinguish meaningful clusters of sequen-
ces through its decomposition into peaks. This decomposition in
particular allows us to distinguish outbreak clusters to obtain
insights regarding natural virus evolution. One may ask whether
such a decomposition is also revealed through phylogenetic trees
or with other clustering methods which are commonly used in
machine learning.
To explore this, we first constructed a phylogenetic tree (see the
“Methods” section) using PASTA56. Coloring the sequences in
the tree according to their peak identification (similar to the color
scheme in Fig. 3) revealed an informative and rather consistent
structure (Fig. 6a). Specifically, peak 1 sequences were largely
located near the trunk of the tree, while all outbreak peaks were
generally grouped in exterior branches. Consistent with Fig. 4,
this result also hints at the possibility of peak 1 (representing
largely unimmunized populations) being a source of all the
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Fig. 4 Circos plot demonstrating peak 1 to be the most densely connected peak in the inferred landscape. A zero-temperature Monte Carlo procedure
(see the “Methods” section) was used to obtain the pathways connecting different peaks in the landscape. For better visualization, only the pathways
among the top 10 peaks are shown. The segments in the outer part of the circle, representing the peaks, are colored according to the scheme in Fig. 3. The
ribbons, representing the pathways that connect the peaks, are colored according to the peak from which the trajectory originated. The width of each
ribbon represents the percentage of the trajectories that originated from peak k and reached a peak k’ k0 ¼ 1; 2; ¼ ; 10; k0≠kð Þ out of all the trajectories
that did not reach peak k. This figure was generated using the web version of Circos68.
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outbreaks. However, importantly, disentangling the peak
1 sequences from the outbreak peak sequences seems difficult
by using just the phylogenetic tree alone (i.e., without coloring the
tree according to our landscape) or even by coloring it according
to spatial or temporal information available in the metadata
(Supplementary Fig. 5a, b). This distinction may be due to the fact
that our model takes into account the couplings between residues,
while phylogenetic trees are generally constructed using a model
that assumes individual residues to evolve independently. In fact,
the peak structure in our inferred landscape, which is crucial to
decouple the natural PV evolution from the vaccine-driven
evolution (as discussed above), was not observed if we ignore the
couplings between residues (only a single peak was observed in a
model inferred using only residue-wise variation; see Supple-
mentary Notes 1 and 2).
We further tested three widely used clustering methods: K-
means, hierarchical, and spectral clustering57 (see the “Meth-
ods” section). As all clustering methods are unsupervised, the
number of clusters to form must be specified as an input. Thus,
we tested each clustering method for two cases. For the first
case, we set the number of clusters to 25, corresponding to the
number of local peaks observed in the vp1 landscape in our
analysis (Fig. 6b). In this case, the K-means and hierarchical
clustering methods merged almost all sequences into a single
cluster. In contrast, the spectral clustering method formed some
clusters that were largely associated with a particular peak,
suggesting that these outbreak clusters could be partially
recovered using this method if the number of clusters to form
is known a priori. However, the peak 1 sequences were
distributed into multiple clusters, with a single cluster only
capturing 37% of these sequences. Thus, the most important
population for our analysis is not well captured using this
approach. For the second case, the number of clusters was
determined by the standard silhouette coefficient metric58,
wherein all clustering methods resulted in a maximum of three
clusters, with almost all sequences falling into one of them.
Thus, these results indicate that the clustering results obtained
with the inferred prevalence landscape, and in particular the
classification of sequences as either outbreak sequences or those
representing natural evolution, is not obtained with standard
clustering approaches. Beyond the PV application at hand, a
more detailed analysis of the use of maximum entropy models
for clustering is a promising topic for future exploration.
PV evolution has higher fitness constraints compared to HIV.
After validating our model as a proxy for the fitness landscape of
vp1, we next compared features of this model with those of two
HIV proteins: p24 and gp160. P24 is the HIV capsid protein and
thus similar to vp1, which is a primary component of the PV
capsid. However, unlike in HIV, the PV capsid protein is used to
enter cells. Thus gp160, the envelope protein that HIV uses to
attach to and enter cells and is subject to antibody responses, also
serves as a meaningful comparison.
We first computed the fitness autocorrelation for each
landscape, which is a statistical measure reflecting how quickly
the predicted fitness varies, on average, as one walks randomly
along the landscape59 (see the “Methods” section). The decay in
the fitness autocorrelation of vp1 was observed to be faster than
that of HIV proteins (Fig. 7a), indicating that the fitness
landscape of the surface protein of PV is relatively more
constrained, i.e., taking a certain number of random steps along
the PV landscape results in relatively larger changes in fitness as
compared to taking the same number of random steps along the
landscape of HIV proteins. The qualitative results remained the
same irrespective of the sequences used to initiate the random
walks (Fig. 7a).
We further compared the average neutrality of each landscape,
which quantifies the average of the maximum number of
mutation steps one can take without much change in fitness
while performing a random walk on the landscape59 (see the
“Methods” section). Based on this measure, the landscape of vp1
appeared to be less neutral than that of both HIV proteins
(Fig. 7b). This result suggests that there is generally a higher
fitness cost upon making mutations in the vp1 fitness landscape
as compared to the HIV proteins. This observed trend was
independent of the number of steps taken in the random walk to
compute the neutrality measure (Fig. 7b). We note that such a
distinction in the evolutionary constraints faced by the PV and
HIV proteins was not evident by using a standard dN/dS analysis
(Supplementary Note 8). Moreover, such difference between the
capsid proteins of PV and HIV was not obvious by using simple
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Fig. 5 Biological validation of the inferred fitness landscape of vp1. a In silico-predicted energy obtained from the prevalence landscape inferred from the
sequences corresponding to peak 1 correlates highly with the experimental fitness measurements. Replicative fitness data was obtained from
literature45,48–50,70 and is presented in Supplementary Table 2. The black dashed line represents a linear least-squares fit to guide the eye. b A large
proportion of the top 1 percentile model couplings are involved in forming a critical vp1–vp4 interface. The vp1 and vp4 pentamers are shown as sets of blue
and green spheres, respectively, while the vp1 residues in both the top 1 percentile model couplings and in the critical vp1–vp4 interface55 are shown as red
spheres. The crystal structure of the poliovirus capsid was downloaded from the PDB database, https://www.rcsb.org/ (ID: 2PLV).
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first-order analysis involving residue-wise entropies (Supplemen-
tary Fig. 6).
Discussion
High mutation rate is an important characteristic of viruses that
can enable them to evade immune responses and propagate
infection. In addition, the capability of a virus to evade adaptive
immunity and efficiently propagate infection is also tied to its
ability to retain functionality when mutated (in other words, its
ability to remain fit). Here, for the case of PV, we have shown that
despite the fact that PV is highly mutable, a partial reason for the
high efficacy of the PV vaccine may be due to its rigid fitness
constraints, which provide limited pathways for escaping vaccine-
directed immune pressure. This was accomplished by employing
computational methods to infer a fitness landscape of the PV
capsid protein, vp1, and comparing it with corresponding land-
scapes of HIV proteins. Compared with HIV, our analysis
demonstrated that PV is far less tolerant to mutations, and is
under much higher intrinsic fitness constraints, making it an
easier target for natural or vaccine-induced immune responses.
Inferring a meaningful fitness landscape for PV is challenging
since the available sequence data reflecting circulating viral strains
is strongly biased by the effects of long-standing functioning
vaccines. By analyzing a low-dimensional decomposition of the
inferred prevalence landscape, we showed that this bias can be
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significantly attenuated, producing a meaningful representative
landscape of PV’s evolution in largely unimmunized populations
under intrinsic fitness constraints. This was validated by com-
paring predictions from the model with experimental fitness
measurements, which showed very good agreement. This simple
correspondence between the prevalence and intrinsic fitness
landscape of vp1 suggests that it may also involve the key factors
identified previously for this correspondence to hold in HIV
proteins16. That is, ineffective natural immune responses against
vp1 (among reported infections in unimmunized population)
may be diverse, and PV may involve reversion of patient-specific
immune-escape mutations to wild-type upon infection of a new
patient who does not target the same region. The reported cases
of infection in OPV-vaccinated patients due to reversion of the
vaccine strain to wild-type60 provides support for the involve-
ment of the latter factor in PV infection.
In addition to identifying a large region of the inferred land-
scape that is reflective of intrinsic fitness of PV, investigation of
the other regions of the landscape—found to reflect isolated
outbreaks in largely immunized populations—offers insight into
the origin and evolutionary nature of such outbreaks. While PV is
generally not recognized as escaping vaccine-induced immunity
through the process of antigenic drift42 (i.e., by acquiring muta-
tions at the antigenic sites which are the primary targets of
antibodies), our analysis determined that viral strains in distinct
outbreaks tend to carry antigenic mutations (Fig. 2), suggesting
the potential importance of escape mutations in triggering out-
breaks. These outbreak-associated strains carried other non-
antigenic mutations as well which were found to be strongly
coupled to the antigenic mutations (Supplementary Note 9).
These non-antigenic mutations seemingly hitchhike with the
antigenic mutation that potentially escapes population immunity
and facilitates an outbreak in a particular region. This is remi-
niscent of the evolution of influenza virus61,62, in which multiple
neutral or deleterious mutations linked to an antigenic mutation,
which enables escape from population immunity, have been
observed to proceed to fixation collectively.
While our study has focused primarily on PV, the proposed
approach of analyzing the structure of the prevalence landscape
(local peaks, etc.) may be applied more broadly for potentially
isolating the intrinsic fitness landscape of viruses from strong
vaccine-driven effects. MeV is one such example for which an
effective vaccine has been in use for the last 50 years2. In a recent
study, the notable effectiveness of the MeV vaccine was also
suggested to be associated with the constrained evolution of
MeV63. Moreover, it would be interesting to apply our approach
to IAV, which is known to be constantly evolving under effective
natural and vaccine-induced immune pressure via antigenic
drift29,64. In contrast to spatio-temporally localized evolution of
PV (Supplementary Fig. 5b), the hemagglutinin protein of IAV,
which is the main target of neutralizing antibodies, is known to
evolve in temporally localized clusters64 while being geo-
graphically well-mixed (Supplementary Fig. 5c). Nevertheless,
analyzing the structure of the hemagglutinin landscape would be
interesting and may be informative.
Methods
Sequence data: acquisition and preprocessing. All sequences available for PV
were downloaded from the National Center for Biotechnology Information (NCBI)
database (http://www.ncbi.nlm.nih.gov/). These sequences were then post-
processed for classification into serotypes. The metadata present in the header of
the downloaded sequences (in FASTA format) lacked important information, e.g.,
collection date, country/region, etc. Thus, an in-house code was written in
MATLAB to obtain this information. In this code, the NCBI database is accessed
using the accession number of the sequence and a metadata header is formed that
contains the information of the collection date of the sequence, its country of
origin, and the publication details (title of the report and journal name). We
focused on PV serotype 1 (PV1) as it had the largest number of available sequences
(Supplementary Fig. 7a). Among all serotype 1 proteins, we chose to focus on the
vp1 capsid protein as it is the most exposed surface protein and is also a major
target of neutralizing antibodies19. Analyzing the number of sequences available for
each protein, vp1 also had the highest number of sequences (2261 sequences), as
well as the highest ratio of number of sequences to the number of residues
(Supplementary Fig. 7b–d), thus aiding statistical analyses.
The data for clade B HIV proteins p24 (8894 sequences) and gp160
(21,451 sequences) was downloaded from the Los Alamos National Laboratory
HIV Sequence Database (http://www.hiv.lanl.gov). Sequences labeled as
problematic or with gaps or ambiguous amino acids at ≥5% residues were removed.
All sequences for a particular protein were arranged in an M ×N matrix,
representing the MSA, where M and N denote the number of sequences and the
number of residues of the protein, respectively. Each row of the MSA represents a
sequence s ¼ s1; s2; ¼ ; sNf g, where si 2 A; R; ¼ ; V ; f g (the 20 amino acids
and the gap). The similarity between any pair of sequences was quantified using the
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Fig. 7 Comparison of the fitness landscapes reveals the constrained evolution of vp1 as compared to HIV proteins. a Comparison of the autocorrelation
of sequence energies of each protein landscape (see the “Methods” section). The x-axis shows the number of random-walk steps (k) for which the
autocorrelation was computed. Results are shown for two sets of starting sequences, which were selected within a Hamming distance (D) of 5 (solid line)
and 30 (dashed line) from the MSA (see the “Methods” section for detail). Note that the fitness landscape becomes flatter for all proteins as we allow the
sequences to move further away from the MSA sequences. This is expected, since the sequences that are at a large Hamming distance from the MSA will
have relatively lower fitness due to the low probability of observing those sequences (Supplementary Fig. 11). b Comparison of the neutrality of the
landscapes of all three proteins. The neutrality measure quantifies the average maximum Hamming distance covered from an initial sequence in a neutral
walk, where a random step in the walk is only accepted when the change in fitness from the sequence at the previous step is within a small value, ϵ (shown
on the x-axis). For each protein, neutrality was computed for L= 500 (solid line) and 1000 (dashed line) steps.
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similarity matrix Γ, where the (a, b)th entry of Γ represents the similarity between
two sequences a and b and is given by Γab ¼ δ sai ; sbi
  
N , where :h iN indicates the
average taken over N residues, smi is the amino acid at residue i in themth sequence,
and δ(a1, a2) is the Kronecker delta function which is equal to 1 when a1= a2 and 0
otherwise. Principal component analysis of the similarity matrix of the vp1 protein
revealed two large clusters (Supplementary Fig. 8). A detailed study of the reports
associated with each sequence helped to determine that one cluster (purple)
consisted primarily of wild-type sequences, while the other cluster (orange)
represented the VDPV sequences. Because VDPV sequences were obtained from
studies following the evolution of the vaccine strain in immunized patients, we
reasoned that they were not characteristic of the typical evolution of the virus
under natural constraints65. Thus, we focused on the wild-type 1560 sequences
(Supplementary Data 1) for further analysis.
Maximum entropy model to infer prevalence landscape. The approach for
inferring the prevalence landscape is to seek the least-biased model (i.e., the one for
which the entropy is maximum66) that fits the single and double mutant prob-
abilities observed in the MSA. When this approach was first applied to HIV10, a
simplified mapping was employed in which each sequence was represented by a
binary string, with a ‘0’ at a given position indicating the consensus amino acid,
and a ‘1’ indicating a mutant amino acid. With this mapping, the maximum
entropy distribution took the form of an Ising model. However, while the
underlying binary approximation is reasonable for conserved proteins, it results in
loss of information when dealing with highly variable proteins, since it discards the
identity of the mutant amino acids at each residue in the sequence. Thus, the
approach has been extended to account for the mutant amino acid identities, in
which case the maximum entropy distribution takes the form of a Potts model11.
In the HIV sequence data, there is a bias due to multiple sequences per patient.
Such information is not available for the PV sequence data. Examining the reports
associated with these sequences (Supplementary Data 1), only a single report67
studied viral evolution within a patient over time. Thus, we assumed each PV
sequence to be sampled from a different patient. To compensate for this bias in the
HIV data, a weighting was applied and the observed single and double mutant
probabilities of the MSA were computed as follows:
pi xð Þ ¼
1
W
XM
m¼1
wmδ s
m
i ; x
 
and pij x; yð Þ ¼
1
W
XM
m¼1
wmδ s
m
i ; x
 
δ smj ; y
 
; ð2Þ
where pi(x) is the frequency of observing a mutant x at residue i, pij(x, y) is the
frequency of simultaneously observing a mutant x at residue i and a mutant y at
residue j. For the HIV proteins, the sampling bias caused by having multiple
samples taken from the same patient is compensated for by the weight, wm= 1/zm,
where zm is the total number of sequences in the MSA obtained from the same
patient from whom sequence m was acquired. The normalization factor W is the
number of unique patients.
We selected a limited number of mutant amino acids at each residue (instead of
all 21 possibilities) such that at least 90% of the total entropy at that residue was
captured. We chose this particular number to avoid fitting parameters for the rarely
observed mutant amino acids. Specifically, we obtained the minimum number of
mutant amino acids ai at residue i such that

Xai
j¼1
pi xj
 
ln pi xj
 
 0:9 ´
X21
j¼1
pi xj
 
ln pi xj
 
: ð3Þ
For the maximum entropy model, the probability of observing an arbitrary
sequence b is given by66
P bð Þ ¼ e
E bð Þ
Q
; ð4Þ
where
E bð Þ ¼ 
XN
i¼1
hi bið Þ 
XN1
i¼1
XN
j¼iþ1
Jij bi; bj
 
ð5Þ
is referred to as the energy of the sequence b and Q ¼Pb eE bð Þ is a normalization
factor. Note that bi represents the amino acid present at the ith residue in the
sequence b. The model parameters hi(x) (fields) and Jij(x, y) (couplings) are
specified such that the single and double mutant probabilities,
p^i xð Þ ¼
X
b
δ bi; xð ÞP bð Þ and p^ij x; yð Þ ¼
X
b
δ bi; xð Þδ bj; y
 
P bð Þ; ð6Þ
match those of the observed data (given in Eq. (2)). The inference of these
parameters is referred to as the inverse Potts problem. This inverse problem is
known to have no analytical solution for systems with large dimensions, and thus
one requires the use of numerical algorithms24,25. For this, we utilized a Potts
extension26 of the ACE method, originally proposed for the Ising model in
refs. 24,25. This code is available at https://github.com/johnbarton/ACE.
We generated samples from the predicted model using a Markov Chain Monte
Carlo (MCMC) method10. The inferred model was first checked by making sure
that the single and double mutant probabilities of the MCMC samples agree with
those of the MSA. It was further validated by comparing the observed triple mutant
probabilities of the MSA with those of the MCMC samples, along with the
probability of observing a sequence with r mutations. The aforementioned
validation tests provide a somewhat coarse-grained mutant versus non-mutant
quantification of the model, however they do not capture the ability of the model to
describe the specific identities of the mutants (i.e., the specific amino acids
involved). Additional tests were therefore performed to characterize these features.
Specifically, we compared the probability distribution of the number of first and
second most-prevalent mutant amino acids observed per sequence in the MSA with
the corresponding distribution in the MCMC samples.
Characterizing the protein landscape by its local peaks. From Eq. (1), we
observe that the lower the energy of a sequence, the higher its prevalence/predicted
fitness. Thus, for each inferred landscape, we investigated the local fitness maxima
(or energy minima)20,21. Each such maximum is identified with a sequence having
a fitness (energy) that is higher (lower) than all of its neighbors (those that are one
mutation away in Hamming distance). We refer to such a sequence as a peak
sequence. For any given starting sequence b, a local maximum was found by
following a steepest ascent walk. At the first step, the fitness of all neighbors of
sequence b in the landscape was calculated and the neighboring sequence with the
highest fitness was selected. The procedure was repeated until a sequence was
reached which has higher fitness than all of its neighbors. Repeating the above
procedure with each MSA sequence as the starting sequence, the number of
obtained unique local maxima represented the number of local peaks in the
landscape.
Definition of statistical significance. The statistical significance of the observed
fraction of mutations on antigenic sites in each peak sequence (Fig. 2c) was
quantified using a p-value, which is the probability of observing a result as extreme
as or more extreme than the one being studied, assuming a null hypothesis were
true. For example, assume that there are j antigenic sites in vp1 and that a peak
sequence, comprising n mutations, includes mutations on i of the j antigenic sites.
Here, the null hypothesis would be that the observed mutations on the n sites in
this peak sequence arose from a random selection from the N sites of the protein.
Assuming that the null hypothesis is true, the p-value is the probability that a peak
sequence would include mutations on at least i of the j antigenic sites and is
calculated as follows:
p ¼
Xmin j;nð Þ
q¼i
j
q
 	
N  j
n q
 	
N
n
 	 ð7Þ
A low p-value (p < 0.05) would indicate that the null hypothesis is rejected and
that it is unlikely that such a peak could arise from random chance.
Quantifying the pathways between landscape peaks. We used the zero-
temperature Monte Carlo procedure to quantify the pathways between the inferred
landscape peaks. In this procedure, we started multiple trajectories (600) from each
MSA sequence associated to a particular peak k. In each step of a trajectory, a
random residue in the sequence is selected for mutation. The resulting sequence is
accepted if its fitness is more than the sequence in the previous step (note that this
is different from the steepest ascent procedure which involves exhaustively finding
the neighboring sequence with the highest fitness). This procedure was repeated
until a sequence was reached which has higher fitness than all of its neighbors
(those that are one mutation away in Hamming distance). As expected, an over-
whelming majority of the trajectories (>90%) converge to the respective peak
sequence, i.e., the local maximum of the peak k, with the remaining ones reaching a
peak different from peak k. We recorded these latter trajectories as they represent
the pathways that connect the peak k to the other peaks in the inferred landscape.
For visualizing these pathways, we used the web version of Circos68 which is
available at http://mkweb.bcgsc.ca/tableviewer/visualize/.
Constructing the phylogenetic tree. PASTA v1.6.456, software freely available at
https://github.com/smirarab/pasta, was used to construct a maximum-likelihood
phylogenetic tree (Fig. 6a) using the available vp1 data. For a fair comparison with
other methods, the amino acid sequence data was provided as an input to PASTA.
This software automatically selects the appropriate parameters for tree estimation
based on the provided sequence data.
Dendroscope v3.5.969, software freely available at http://dendroscope.org/, was
used for visualizing the phylogenetic tree and re-rooting it with the earliest
available sequence (accession number: AF528768). The rectangular and circular
phylogram layouts available in Dendroscope were used. The sequences, that form
the leaves of the tree, were colored using an in-house code.
Implementation details of standard clustering methods. We tested whether our
observed clustering of sequence data associated with largely unimmunized popu-
lation is obtained with three standard clustering methods (Fig. 6b). The imple-
mentation details of these methods are as follows:
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K-means clustering: We used the MATLAB function kmeans (Statistical and
Machine Learning Toolbox) to implement this clustering method using the
vp1 sequence data. Results are shown for the default distance measure of squared
Euclidean distance. The qualitative results remained the same when other distance
measures were used.
Hierarchical clustering: We used the MATLAB function linkage (Statistical
and Machine Learning Toolbox) to obtain an agglomerative hierarchical cluster
tree using the default distance measure of Euclidean distance. Clusters were then
formed from this agglomerative tree using the MATLAB function cluster
(Statistical and Machine Learning Toolbox). The qualitative results remained the
same when other distance measures were used.
Spectral clustering: The un-normalized spectral clustering algorithm57 was
implemented in MATLAB using the fully connected graph for obtaining clusters.
All of the above methods require the number of clusters to be specified as an
input. However, the optimal number of clusters is generally not known. To
determine it, each method was used to construct 1–40 clusters and the MATLAB
function silhouette (Statistical and Machine Learning Toolbox) was used to
compute the silhouette coefficient58 for each clustering solution. The number of
clusters that maximize the silhouette coefficient was selected as optimum.
Measures for comparing the landscape ruggedness of proteins. We used two
measures to compare the ruggedness of the inferred landscape of vp1 and various
proteins of HIV59:
Autocorrelation: Autocorrelation quantifies the average change in fitness as one
moves randomly along the fitness landscape. We began with Nc= 106 random
sequences generated within a Hamming distance D from the MSA. Using each of
these sequences as a starting point, we simulated a 50-step random walk and
recorded the fitness at each step. The autocorrelation of the sequence energies at
the kth step is
ak ¼
E b0
 
E bk
  
Nc
 E b0  Nc E bk
  
Ncffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
E b0
 2D E
Nc
 E b0  2Nc
r ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
E bk
 2D E
Nc
 E bk  2Nc
r ð8Þ
for k ¼ 1; 2; ¼ ; 50, and bk representing a sequence at the kth step. Recall that
:h iNc indicates the average taken over Nc sequences. If ak decreases sharply with
small increase in k, it indicates a rapid change in fitness along sequence trajectories
on the landscape, and vice versa.
Neutrality: Neutrality is defined by the maximum number of mutation steps
that can be taken in the landscape with a very small change ϵð Þ in the fitness.
Using Nc= 106 random sequences as starting points, we performed a quasi-
neutral random walk consisting of L ∈ {500,1000} steps on each sequence. At
each step, we selected a random residue in the current sequence bk for mutation,
leading to a new sequence bk0. This mutation was accepted if the difference in
fitness of the two sequences is less than some small value ϵ, otherwise we selected
bk+1= bk. At each step k, we computed the Hamming distance dk between bk
and the starting sequence b0. At the end of the random walk, we recorded
the maximum Hamming distance for each trajectory. We quantified the
neutrality of the landscape by the mean of the maximum Hamming distances,
taken over the trajectories commencing at the Nc random starting sequences, i.e.,
maxkd
k
 
Nc
.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The detailed metadata compiled for vp1 sequences from the NCBI database and literature
is provided in Supplementary Data 1. The experimental fitness measurements for vp1
compiled from literature are included in Supplementary Table 2.
Code availability
All the data and scripts (mostly written in MATLAB) for reproducing the results can be
found at https://github.com/ahmedaq/PV-vp1.
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